Atlas Trials

Expanded Access to Nivolumab (Opdivo)

Clinical trial NCT03126643 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT03126643
Sponsor
Bristol-Myers Squibb
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Pediatric Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.